SCOPUS 정보 검색 플랫폼

European Respiratory Journal

Volumn 39, Issue 3, 2012, Pages 770-772

On linezolid efficacy and tolerability

(5) De Lorenzo, S a Centis, R b D'Ambrosio, L b Sotgiu, G c Migliori, G B b

a Reference Hospital for MDR and HIV TB (Italy)

b WORLD HEALTH ORGANIZATION (Switzerland)

c UNIVERSITY OF SASSARI (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CAPREOMYCIN; CLOFAZIMINE; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; PYRAZINAMIDE; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; TERIZIDONE;

ANEMIA; ANTIBIOTIC RESISTANCE; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG RESISTANT TUBERCULOSIS; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; INFECTION RESISTANCE; LENGTH OF STAY; LETTER; LEUKOPENIA; MULTIDRUG RESISTANT TUBERCULOSIS; NEUROPATHY; PRIORITY JOURNAL; SIDE EFFECT; SPUTUM CULTURE; SPUTUM SMEAR; THROMBOCYTE COUNT; TREATMENT DURATION; TUBERCULOSIS;

ACETAMIDES; ADULT; ANTITUBERCULAR AGENTS; COHORT STUDIES; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; TREATMENT OUTCOME;

EID: 84860324887 PISSN: 09031936 EISSN: 13993003 Source Type: Journal
DOI: 10.1183/09031936.00116011 Document Type: Letter

Times cited : (23)

References (10)

1
- 80053082369
- Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis
- Villar M, Sotgiu G, D'Ambrosio L, et al. Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis. Eur Respir J 2011; 38: 730-733.
- (2011) Eur Respir J , vol.38 , pp. 730-733
- Villar, M.¹ Sotgiu, G.² D'Ambrosio, L.³

2
- 77954453440
- World Health Organization. Publication No. WHO/HTM/TB/2010.3. Geneva, World Health Organization
- World Health Organization. Multidrug and extensively drug resistant TB (M/XDR-TB): 2010 global report on surveillance and response. Publication No. WHO/HTM/TB/2010.3. Geneva, World Health Organization, 2010.
- (2010) Multidrug and Extensively Drug Resistant TB (M/XDR-TB): 2010 Global Report on Surveillance and Response

3
- 36849040101
- Clinical and operational value of the extensively drug-resistant tuberculosis definition
- DOI 10.1183/09031936.00077307
- Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007; 30: 623-626. (Pubitemid 351194820)
- (2007) European Respiratory Journal , vol.30 , Issue.4 , pp. 623-626
- Migliori, G.B.¹ Besozzi, G.² Girardi, E.³ Kliiman, K.⁴ Lange, C.⁵ Toungoussova, O.S.⁶ Ferrara, G.⁷ Cirillo, D.M.⁸ Gori, A.⁹ Matteelli, A.¹⁰ Spanevello, A.¹¹ Codecasa, L.R.¹² Raviglione, M.C.¹³ Ortmann, J.¹⁴ Kirsten, D.¹⁵ Ruesch-Gerdes, S.¹⁶ Piana, F.¹⁷ Ferrarese, M.¹⁸ De Iaco, G.¹⁹ De Lorenzo, S.²⁰ more..

4
- 80053067126
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
- Falzon D, Jaramillo E, Schünemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
- (2011) Eur Respir J , vol.38 , pp. 516-528
- Falzon, D.¹ Jaramillo, E.² Schünemann, H.J.³

5
- 63849276723
- Epidemiology and clinical management of XDR-TB: A systematic review by TBNET
- Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009; 33: 871-881.
- (2009) Eur Respir J , vol.33 , pp. 871-881
- Sotgiu, G.¹ Ferrara, G.² Matteelli, A.³

6
- 69249137544
- A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
- Migliori GB, Eker B, Richardson MD, et al. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis. Eur Respir J 2009; 34: 387-393.
- (2009) Eur Respir J , vol.34 , pp. 387-393
- Migliori, G.B.¹ Eker, B.² Richardson, M.D.³

7
- 79251511858
- Treatment of tuberculosis: Update 2010
- Yew WW, Lange C, Leung CC. Treatment of tuberculosis: update 2010. Eur Respir J 2011; 37: 441-462.
- (2011) Eur Respir J , vol.37 , pp. 441-462
- Yew, W.W.¹ Lange, C.² Leung, C.C.³

8
- 73249123564
- What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis?
- Yew WW, Chang KC, Chau CH. What is the optimal dosage of linezolid in treatment of complicated multidrug-resistant tuberculosis? Eur Respir J 2009; 34: 1492-1494.
- (2009) Eur Respir J , vol.34 , pp. 1492-1494
- Yew, W.W.¹ Chang, K.C.² Chau, C.H.³

9
- 77951179468
- Assessment of linezolid efficacy and safety in MDR- and XDR-TB: An Indian perspective
- Udwadia ZF, Sen T, Moharil G. Assessment of linezolid efficacy and safety in MDR- and XDR-TB: an Indian perspective. Eur Respir J 2010; 35: 936-938.
- (2010) Eur Respir J , vol.35 , pp. 936-938
- Udwadia, Z.F.¹ Sen, T.² Moharil, G.³

10
- 72049096404
- Linezolid in the treatment of multidrug-resistant tuberculosis
- Schecter GF, Scott C, True L, et al. Linezolid in the treatment of multidrug-resistant tuberculosis. Clin Infect Dis 2010; 50: 49-55.
- (2010) Clin Infect Dis , vol.50 , pp. 49-55
- Schecter, G.F.¹ Scott, C.² True, L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.